Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (311-320 of 426) with videos related to

Pageof 43
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 14, 2022
Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational StudyFrancesca Mannucci, Giacomo Vitturi, Luca Benacchio, et al.
Diabetes, Obesity & Metabolism|July 2, 2025
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney diseaseGian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.
Diabetes/Metabolism Research and Reviews|June 11, 2025
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert GroupConcetta Irace, Angelo Avogaro, Federico Bertuzzi, et al.
Diabetologia|June 16, 2022
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular diseaseSaula Vigili de Kreutzenberg, Alessandra Giannella, Giulio Ceolotto, et al.
Plos One|March 23, 2012
The peritoneum as a natural scaffold for vascular regenerationStefano Bonvini, Mattia Albiero, Luca Ferretto, et al.
Clinical Science (London, England : 1979)|April 8, 2014
Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndromeGiulio Ceolotto, Saula Vigili De Kreutzenberg, Arianna Cattelan, et al.
BMJ Open Diabetes Research & Care|May 27, 2024
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetesMatteo Franchi, Giacomo Pellegrini, Angelo Avogaro, et al.
Vascular Pharmacology|December 9, 2014
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patientsGian Paolo Fadini, Mauro Rigato, Federico Boscari, et al.
Diabetes/Metabolism Research and Reviews|March 3, 2020
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach StudyRiccardo C Bonadonna, Andrea Giaccari, Raffaella Buzzetti, et al.
Cardiovascular Diabetology|July 17, 2021
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetesMario Luca Morieri, Valentina Perrone, Chiara Veronesi, et al.
Pageof 43

Showing results (311-320 of 426) with videos related to

Sort By:
Pageof 43
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 14, 2022
Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational StudyFrancesca Mannucci, Giacomo Vitturi, Luca Benacchio, et al.
Diabetes, Obesity & Metabolism|July 2, 2025
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney diseaseGian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.
Diabetes/Metabolism Research and Reviews|June 11, 2025
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert GroupConcetta Irace, Angelo Avogaro, Federico Bertuzzi, et al.
Diabetologia|June 16, 2022
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular diseaseSaula Vigili de Kreutzenberg, Alessandra Giannella, Giulio Ceolotto, et al.
Plos One|March 23, 2012
The peritoneum as a natural scaffold for vascular regenerationStefano Bonvini, Mattia Albiero, Luca Ferretto, et al.
Clinical Science (London, England : 1979)|April 8, 2014
Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndromeGiulio Ceolotto, Saula Vigili De Kreutzenberg, Arianna Cattelan, et al.
BMJ Open Diabetes Research & Care|May 27, 2024
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetesMatteo Franchi, Giacomo Pellegrini, Angelo Avogaro, et al.
Vascular Pharmacology|December 9, 2014
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patientsGian Paolo Fadini, Mauro Rigato, Federico Boscari, et al.
Diabetes/Metabolism Research and Reviews|March 3, 2020
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach StudyRiccardo C Bonadonna, Andrea Giaccari, Raffaella Buzzetti, et al.
Cardiovascular Diabetology|July 17, 2021
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetesMario Luca Morieri, Valentina Perrone, Chiara Veronesi, et al.
Pageof 43